Addiction treatment-related employment barriers: The impact of methadone maintenance

Journal of Substance Abuse Treatment

Volumn 43, Issue 3, 2012, Pages 276-284

  Richardson, Lindsey ^a,b   Wood, Evan ^a,c   Montaner, Julio ^a   Kerr, Thomas ^a,c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Addiction treatment; Employment; Injection drug use; Methadone maintenance therapy; Vancouver

Indexed keywords

METHADONE;

ADULT; ARTICLE; CANADA; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; EMPLOYMENT STATUS; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; SURVIVAL;

ADULT; BRITISH COLUMBIA; COHORT STUDIES; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84866540636     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.12.008     Document Type: Article

References (58)

1. Allison P.D. Discrete-time methods for the analysis of event histories. Sociological Methodology 1982, 13:61-98.
2. Allison P.D. Event history analysis: Regression for longitudinal event data 1984, Sage Publications, London.
3. Anderson J.F., Warren L.D. Client retention in the British Columbia methadone program, 1996-1999. Canadian Journal of Public Health 2004, 95:104-109.
4. Backmund M., Meyer K., Eichenlaub D., Schultz C. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Drug and Alcohol Dependence 2001, 64:173-180.
5. Barnas C., Rossmann M., Roessler H., Riemer Y., Fleischhacker W. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: Familiarity and preference. Journal of Clinical Psychopharmacology 1992, 12:397-402.
6. Beck N., Katz J.N., Tucker R. Taking time seriously: Time-series-cross-section analysis with a binary dependent variable. American Journal of Political Science 1998, 42:1260-1288.
7. Blankertz L., Magura S., Staines G., Madison E., Spinelli M., Horowitz E., et al. A new work placement model for unemployed methadone maintenance patients. Substance Use & Misuse 2004, 39:2239-2260.
8. Blankertz L., Spinelli M., Magura S., Balit P., Madison E., Staines G., et al. Integrating fieldwork into employment counseling for methadone-treatment patients. Journal of Employment Counseling 2005, 42:113-124.
9. British Columbia Ministry of Social Development Ministry fact sheets. Downloaded from:, 26 July 2011. http://www.hsd.gov.bc.ca/fs.htm.
10. Byrne A., Wodak A. Data do not support buprenorphine as a first-line treatment for addiction. American Journal of Psychiatry 2007, 164:1757.
11. Castellani B., Wedgeworth R., Wootton E., Rugle L. A bi-directional theory of addiction: Examining coping and the factors related to substance relapse. Addictive Behaviors 1997, 22:139-144.
12. Comer S., Sullivan M., Yu E., Rothenberg J., Kleber H., Kampman K., et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence: A randomized, placebo-controlled trial. Archives of General Psychiatry 2006, 63:210-218.
13. Crisp A., Gelder M., Rix S., Meltzer H., Rowlands O. Stigmatization of people with mental illnesses. British Journal of Psychiatry 2000, 177:4-7.
14. Darke S., Sims J., McDonald S., Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000, 95:687-695.
15. DeBeck K., Wood E., Qi J., Fu E., McArthur D., Montaner J., et al. Interest in low-threshold employment among people who inject illicit drugs: Implications for street disorder. International Journal of Drug Policy 2011, 22:376-384.
16. DeMaria P.A., Sterling R., Weinstein S.P. The effects of stimulant and sedative use on treatment outcomes of patients admitted to methadone maintenance treatment. American Journal of Addiction 2000, 9:145-153.
17. Dooley D., Fielding J., Levy L. Health and unemployment. Annual Review of Public Health 1996, 17:449-465.
18. Fountain J., Strang J., Gossop M., Farrell M., Griffiths P. Diversion of prescribed drugs by drug users in treatment: Analysis of the UK market and new data from London. Addiction 2000, 95:393-406.
19. Gibson D.R., Flynn N.M., McCarthy J.J. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 1999, 13:1807-1818.
20. Hariri S. New opioid addiction med hits Canada: Buprenorphine offers alternative to methadone, reduces OD risk. National Review of Medicine 2008, 5:1. Downloaded 4 April 2011 from. http://www.nationalreviewofmedicine.com/issue/2008/01_15/5_patients_practice06_1.html.
21. Hermalin J.A., Steer R.A., Platt J.J., Metzger D.S. Risk characteristics associated with chronic unemployment in methadone clients. Drug and Alcohol Dependence 1990, 26:117-125.
22. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D. A 33-year follow-up of narcotics addicts. Archives of General Psychiatry 2001, 58:503-508.
23. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginzburg H.M. Drug abuse treatment: A national study of effectiveness 1989, University of North Carolina Press, Chapel Hill.
24. Hulse G., Comer S., Sullivan M. The development of sustained-release naltrexone and clinical use in treating opiate dependence. Contemporary neuroscience: Opiate receptor and antagonists: From bench to clinic 2009, 675-688. Humana, New York. R. Dean, E. Bilsky, S. Negus (Eds.).
25. Jenkins S. Easy estimation methods for discrete-time duration models. Oxford Bulletin of Economics and Statistics 1995, 57:129-138.
26. Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine 2000, 343:1290-1297.
27. Joseph H., Stancliff S., Langrod J. Methadone maintenance treatment: A review of historical and clinical issues. The Mount Sinai Journal of Medicine 2000, 67:347-364.
28. Lundgren L.M., Schilling R.F., Ferguson F., Davis K., Amodeo M. Examining drug treatment program entry of injection drug users: Human capital and institutional disaffiliation. Evaluation and Program Planning 2003, 26:123-132.
29. Magura S. The role of work in substance dependency treatment: A preliminary overview. Substance Use & Misuse 2003, 38:1865-1876.
30. Magura S., Staines G.L. Introduction: New directions for vocational rehabilitation in substance user treatment: Rebuilding damaged lives. Substance Use & Misuse 2004, 39:2157-2164.
31. Magura S., Staines G., Blankertz L., Madison E. The effectiveness of vocational services for substance users in treatment. Substance Use & Misuse 2004, 39:2165-2213.
32. Mattick R.P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2008, 2:CD002207. Art. No.
33. Murphy S., Irwin J. Living with the dirty secret: Problems of disclosure for methadone maintenance clients. Journal of Psychoactive Drugs 1992, 24:257-264.
34. Neale J., Kemp P. Employment and problem drug use: The role of employment in recovery from problem drug use. Substance misuse: The implications of research, policy and practice 2009, 94-101. Jessica Kingsley Publishers, London. J. Barlow (Ed.).
35. Nosyk B., Marsh D.C., Sun H., Schechter M.T., Anis A.H. Trends in methadone maintenance treatment participation, retention and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. Journal of Substance Abuse Treatment 2010, 39:22-31.
36. Nutt D., King L.A., Saulsbury W., Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet 2007, 369:1047-1053.
37. Parran T.V., Adelmana C.A., Merkin B., Pagano M.E., Defranco R., Ionescu R.A., et al. Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy. Drug and Alcohol Dependence 2010, 106:56-60.
38. Platt J.J. Vocational rehabilitation of drug abusers. Psychological Bulletin 1995, 117:416-433.
39. Preston K., Umbricht A., Epstein D. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Archives of General Psychiatry 2000, 57:395-404.
40. Price R.H., Burke A.C., D'Aunno T.A., Klingel D.M., McCaughrin W.C., Rafferty J.A., et al. Outpatient drug abuse treatment services, 1988: Results of a national survey. Improving drug abuse treatment (NIDA Research monograph 106 1991, 63-92. U.S. Government Printing Office, Washington, DC. R.W. Pickens, C.G. Leukefeld, C.R. Schuster (Eds.).
41. Reif S., Horgan C.M., Ritter G.A., Tompkins C.P. The impact of employment counselling on substance user treatment participation and outcomes. Substance Use & Misuse 2004, 39:2391-2424.
42. Ritter A., Di Natalie R. The relationship between take-away methadone policies and methadone diversion. Drug and Alcohol Review 2005, 24:347-352.
43. Rosenbaum M., Washburn A., Knight K., Kelley M., Irwin J. Treatment as harm reduction, defunding as harm maximization: The case of methadone maintenance. Journal of Psychoactive Drugs 1996, 28:241-249.
44. Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., et al. Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. Journal of the American Medical Association 2000, 283:1303-1310.
45. Shepard D.S., Reif S. The value of vocational rehabilitation in substance user treatment: A cost effectiveness framework. Substance Use & Misuse 2004, 39:2581-2609.
46. StataCorp Statistical software: Release 11.0 2001, Stata Corporation, College Station, TX.
47. Sterling R.C., Gottheil E., Glassman S.D., Weinstein S.P., Serota R.D., Lundy A. Correlates of employment: A cohort study. The American Journal of Drug and Alcohol Abuse 2001, 27:137-146.
48. Svikis D.S., Keyser-Marcus L., Stitzer M., Rieckmann T., Safforde L., Loeb P., et al. Randomized multi-site trial of the job seekers' workshop in patients with substance use disorders. Drug and Alcohol Dependence 2012, 120:55-64.
49. Tyndall M.W., Curri S., Spittal P., Li K., Wood E., O'Shaughnessy M.V., et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003, 17:887-893.
50. Vaillant G.E. A 20 year follow-up of New York narcotic addicts. Archives of General Psychiatry 1973, 29:237-241.
51. Vaillant G.E. What can long-term follow-up teach us about relapse and prevention of relapse in addiction?. British Journal of Addiction 1988, 83:1147-1157.
52. Varenbut M., Teplin D., Daiter J., Raz B., Worster A., Emadi-Konjin P., et al. Tampering by office-based methadone maintenance patients with methadone take home privileges: A pilot study. Harm Reduction Journal 2007, 4:1-15.
53. Ward J., Hall W., Mattick R.P. Role of maintenance treatment in opioid dependence. Lancet 1999, 353:221-226.
54. Ward J., Mattick R.P., Hall W. The effectiveness of methadone maintenance treatment: An overview. Drug and Alcohol Review 1994, 13:327-335.
55. West S.L. The utilization of vocational rehabilitation services in substance abuse treatment facilities in the U.S. Journal of Vocational Rehabilitation 2008, 29:71-75.
56. Wood E., Tyndall M.W., Spittal P.M., Li K., Kerr T., Hogg R.S., et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. Canadian Medical Association Journal 2001, 165:405-410.
57. World Health Organization Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: Position paper. UNAIDS Position Paper: Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention 2004, United Nations, Geneva.
58. Zanis D., Coviello D., Alterman A., Appling S. A community-based trial of vocational problem-solving to increase employment among methadone patients. Journal of Substance Abuse Treatment 2001, 21:19-26.